“…It is also possible that the dose of MAPK activity generated by the mutant RET kinase might be su cient to elicit inappropriate proliferation (leading to C-cell hyperplasia and/or MTC), but not high enough to trigger terminal di erentiation, unlike the MAPK activity generated by DRaf-1:ER. Other groups have demonstrated that low level raf-1 activity, such as might be caused by activated RET, is mitogenic, while high level raf-1 activity, like that caused by DRaf-1:ER induction, induces growth arrest (Sewing et al, 1997;Woods, et al, 1997). An additional possibility is that the DRaf-1:ER construct and/or mutant RET protein target not just MEK and MAPK, but additional di erentiation or proliferation speci®c substrates, respectively, as has been suggested by Kuo et al (1996Kuo et al ( , 1997.…”